AstraZeneca Case Leads Off Busy Year of Challenges to Medicare Drug Pricing Law
The first hearing on a potential injunction came the day before CMS is to release pricing proposals on 10 drugs.
AstraZeneca Case Leads Off Busy Year of Challenges to Medicare Drug Pricing Law Read More »
